Seaport Entertainment Group Inc. (SEG Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Matt Partridge - Chief Financial Officer Anton Nikodemus - Chairman, President & Chief Executive Officer Conference Call Participants Operator Greetings, and welcome to the Seaport Entertainment Group First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.

CPA, SCGLY and EWCZ made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 13, 2025.

New partnership offers Omega's operator partners exclusive benefits; Omega takes equity stake in Sunbound. WASHINGTON , May 13, 2025 /PRNewswire/ -- Sunbound , a leader in finance and accounts receivable solutions for senior living operators, today announced a strategic partnership with Omega Healthcare Investors (NYSE: OHI), one of the nation's premier real estate investment trusts (REITs) that provides financing and capital solutions to Skilled Nursing Facility (SNF) and Assisted Living Facility (ALF) operators across the U.S. and the U.K. Through this agreement, Omega's extensive network of operator partners will receive preferred access and pricing to Sunbound's industry-leading payments, accounts receivable …

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common Stock) (or common stock equivalents in lieu thereof), at a purchase price of $1.265 per share of Common Stock. The Company further agreed to issue to …

US stocks hold steady today as CPI eases and tariff relief boosts sentiment. UnitedHealth drops, while Coinbase and Sea Limited post big gains.

GoHealth, Inc. (NASDAQ:GOCO ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants John Shave - Vice President of Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Rob McGuire - Granite Research Pat McCann - Noble Capital Markets James Sidoti - Sidoti & Company Dave Storms - Stonegate Capital Partners Operator Good morning, and welcome to GoHealth's First Quarter 2025 Earnings Conference Call. My name is Tanya, and I will be your operator for today's call.

Snowflake Inc.'s stock is currently undervalued with a 40% potential upside, which is absolutely unfair given the company's prospects to capitalize on AI tailwinds. SNOW's commitment to AI is evident through expanding R&D, partnerships, and initiatives like free AI courses in India, enhancing its market position. Despite fierce competition from tech giants, Snowflake's innovation and differentiation strategies have been successful so far.

GoHealth, Inc. (NASDAQ:GOCO ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants John Shave - Vice President of Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Rob McGuire - Granite Research Pat McCann - Noble Capital Markets James Sidoti - Sidoti & Company Dave Storms - Stonegate Capital Partners Operator Good morning, and welcome to GoHealth's First Quarter 2025 Earnings Conference Call. My name is Tanya, and I will be your operator for today's call.

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has dosed the first patient in its Phase 2 clinical trial of EMP-01 for the treatment of social anxiety disorder (SAD). EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine, is being investigated in an exploratory, randomized, double-blind, placebo-controlled study involving approximately 60 adult participants with SAD.

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has dosed the first patient in its Phase 2 clinical trial of EMP-01 for the treatment of social anxiety disorder (SAD). EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine, is being investigated in an exploratory, randomized, double-blind, placebo-controlled study involving approximately 60 adult participants with SAD.

NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources Corporation Chief Executive Officer, Joel Riddle, said: “We have engaged RBC Capital Markets to progress a farm down of acreage to carry Tamboran through the delineation of gas resources to underpin our Phase 2 strategy. “Tamboran and DWE will continue working together on the Pilot Area, where we are focused on the development of the proposed 40 MMcf/d Shenandoah South Pilot Project. Tamboran's r.

NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources Corporation Chief Executive Officer, Joel Riddle, said: “We have engaged RBC Capital Markets to progress a farm down of acreage to carry Tamboran through the delineation of gas resources to underpin our Phase 2 strategy. “Tamboran and DWE will continue working together on the Pilot Area, where we are focused on the development of the proposed 40 MMcf/d Shenandoah South Pilot Project. Tamboran's r.

EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.

EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.

Five mid-cap AI infrastructure stocks to buy are: INOD, FIVN, PATH, IDCC, AVAV.

Five mid-cap AI infrastructure stocks to buy are: INOD, FIVN, PATH, IDCC, AVAV.

It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.

It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.

Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. CF, MOS and YARIY should benefit from supportive industry fundamentals.

Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. CF, MOS and YARIY should benefit from supportive industry fundamentals.